Related Experiment Video
Updated: Jan 11, 2026

Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
Calmodulinopathies: the need for a registry
Peter J Schwartz1, Lia Crotti1,2
1Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Istituto Auxologico Italiano IRCCS, Via Pier Lombardo, 22 Milano 20135, Italy.
Insights
Calmodulinopathies are rare genetic heart disorders with high sudden cardiac death risk. Enrolling patients in the International Calmodulinopathy Registry (ICamR) is crucial for understanding disease mechanisms and improving patient management.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Calmodulinopathies are rare genetic disorders linked to sudden cardiac death.
- They cause severe long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.
- Current knowledge relies on limited data from the International Calmodulinopathy Registry (ICamR).
Purpose of the Study:
- To address the slow patient accrual in the ICamR.
- To gather sufficient data for comprehensive genotype-phenotype correlation.
- To improve risk stratification and therapeutic management strategies for calmodulinopathy patients.
Main Methods:
- A global call for physician participation in the International Calmodulinopathy Registry (ICamR).
- Encouraging enrollment of all calmodulinopathy cases, including isolated instances.
- Leveraging existing expertise from long QT syndrome research initiatives.
Main Results:
- Patient accrual in the ICamR is currently insufficient for robust analysis.
- Limited data hinders the definition of the full clinical spectrum and genotype-phenotype correlations.
- Progress in understanding and managing calmodulinopathies is significantly delayed.
Conclusions:
- Increased patient enrollment in the ICamR is urgently needed.
- Expanded registry data is essential for advancing calmodulinopathy research.
- Collaborative global efforts are required to improve patient outcomes.
Abstract:
Calmodulinopathies are very rare genetic disorders associated with a high risk for sudden cardiac death. Disease-causing variants in 1 of the 3 identical CALM genes cause severe forms of long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, or idiopathic ventricular fibrillation, and there are many unanswered questions concerning management and underlying mechanisms. What is currently known depends largely on the initial publications from the ICamR (International Calmodulinopathy Registry). However, progress is delayed because the accrual of patients in ICamR is slow. As we did long ago for long QT syndrome, this is a call for action, requesting doctors all over the world to enroll even their isolated cases in the Registry. This is the only way to obtain, for an adequate number of patients, the data necessary to define the spectrum of clinical manifestations and the genotype-phenotype correlation essential for an improved risk stratification and best therapeutic management. If you are willing to contribute, please contact us.
More Related Videos
06:52Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
Published on: September 29, 2014
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation